735331-82-5

Upstream product

• 555-16-8 4-nitrobenzaldehdye 
• 1694-31-1 tert-butyl acetoacetate 
• 1129-37-9 4-nitrobenzaldehyde oxime 
• 97804-68-7 tert-butyl acetoacetate potassium salt 
• 1011-84-3 4-nitrobenzohydroximoyl chloride 
• 1328941-87-2 C₁₅H₁₆N₂O₅ 

Downstream Products

• 7035-83-8 C₁₁H₁₀N₂O₃ 
• 1264870-22-5 [4-(2-chloro-4-nitrophenyl)piperazin-1-yl]-[3-(4-aminophenyl)-5-methylisoxazol-4-yl]methanone 
• 1264870-23-6 [4-(2-chloro-4-nitro-pheny1)-piperazin-1-yl]-[3-(4-azido-pheny1)-5-methylisoxazol-4-yl]-methanone 

Relevant academic research and scientific papers

ANTIVIRAL COMPOUNDS AND METHODS OF MAKING AND USING THERE OF CROSS REFERENCE TO RELATED APPLICATIONS

Compounds which exhibit antiviral activity, particularly against influenza virus,and methods of making and using there of are described herein. In one embodiment, the compounds are heterocyclic amides containing piperazine and isozazole rings and optionally substituted with one or more substituents. The compounds can be formulated with one or more pharmaceutically acceptable excipients to form compositions suitable for enteralor parenteral administration. The compounds are preferably used to treat or prevent Influenza Ainfections, such as H1N1, H2N2, H3N2, H5N1, H7N7, H1N2, H9N2, H7N2, H7N3, and H10N7.

ANTIVIRAL COMPOUNDS AND METHODS OF MAKING AND USING THEREOF

Compounds which exhibit antiviral activity, particularly against influenza virus, and methods of making and using thereof are described herein. In one embodiment, the compounds are heterocyclic amides containing piperazine and isozazole rings and optionally substituted with one or more substituents. The compounds can be formulated with one or more pharmaceutically acceptable excipients to form compositions suitable for enteral or parenteral administration. The compounds are preferably used to treat or prevent Influenza A infections, such as H1N1, H2N2, H3N2, H5N1, H7N7, H1N2, H9N2, H7N2, H7N3, and H10N7.